Patients with #HF are at risk for thromboembolic events,even when in sinus rhythm
Low-dose #DAOC seem to reduce thromboembolic risk
OAC should be considered in patients with heart failure in sinus rhythm in some circumstances jacc.org/doi/10.1016/j.… @JACCJournals #cardiotwitter
Low-dose #DAOC seem to reduce thromboembolic risk
OAC should be considered in patients with heart failure in sinus rhythm in some circumstances jacc.org/doi/10.1016/j.… @JACCJournals #cardiotwitter
Patients with heart failure should be evaluated for atrial fibrillation or subclinical atrial tachyarrhythmias. Decision to anticoagulate depends on the CHA2DS2-VASc score. #MedTwitter
Heart failure patients in sinus rhythm with a mechanical heart valve, active venous thromboembolism, or hypercoagulable disorder should be anticoagulated. #CardioTwitter @JACCJournals @JavedButler1 @MihaiTrofenciuc
Other conditions in patients with heart failure in sinus rhythm in which anticoagulation could be considered include LA enlargement, asymptomatic mural thrombus, anterior apical akinesis or dyskinesis, prior thromboembolic events, LV aneurysm, and severe LV dysfunction. #HF
Anticoagulants should also be considered in patients with recent ACS or stable coronary artery disease. The decision to initiate anticoagulation therapy is based on the balance between risk for thromboembolic events versus risk for bleeding. #HF #NOAC #MedTwitter @mmamas1973
• • •
Missing some Tweet in this thread? You can try to
force a refresh
